ERASX | RRMGX | ERASX / RRMGX | |
Total Expense Ratio | 0.81 | 1.29 | 63% |
Annual Report Gross Expense Ratio | 0.81 | 1.29 | 63% |
Fund Existence | 11 years | 23 years | - |
Gain YTD | -4.780 | 2.036 | -235% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 2500 | 200,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14B | 26.8B | 52% |
Annual Yield % from dividends | 0.21 | 0.00 | - |
Returns for 1 year | -9.38 | -7.41 | 127% |
Returns for 3 years | 17.88 | 17.64 | 101% |
Returns for 5 years | 17.19 | -2.50 | -688% |
Returns for 10 years | 57.91 | 25.14 | 230% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DBEF | 46.03 | -0.03 | -0.07% |
Xtrackers MSCI EAFE Hedged Equity ETF | |||
HYBL | 28.59 | -0.03 | -0.12% |
SPDR® Blackstone High Income ETF | |||
QQQT | 18.40 | -0.08 | -0.43% |
Defiance Nasdaq 100 Income Target ETF | |||
IHD | 6.18 | -0.03 | -0.48% |
VOYA EMERGING MARKETS HIGH Income DIVIDEND EQUITY FUND | |||
FTXH | 27.30 | -0.50 | -1.79% |
First Trust Nasdaq Pharmaceuticals ETF |